Skip to content

   Pharma Publications

Neuropsychopharmacology
  • A novel stress-based intervention reduces cigarette use in non-treatment seeking smokers
    Published on 2022-09-29
    3 years ago
  • Compulsion and substance use disorder: potential importance of boundary conditions
    Published on 2022-09-29
    3 years ago
  • Synaptic plasticity as a therapeutic target to modulate circuits in psychiatric disorders
    Published on 2022-09-27
    3 years ago
  • Non-sedative cortical EEG signatures of allopregnanolone and functional comparators
    Published on 2022-09-27
    3 years ago
  • Towards an understanding of psychedelic-induced neuroplasticity
    Published on 2022-09-19
    3 years ago
  • Sex-dependent risk factors for PTSD: a prospective structural MRI study
    Published on 2022-09-16
    3 years ago
  • Nucleus of the solitary tract A2 neurons control feeding behaviors via projections to the paraventricular hypothalamus
    Published on 2022-09-16
    3 years ago
« Previous 1 … 117 118 119 120 121 … 143 Next »
Journal of Psychopharmacology
  • It feels real: physiological responses to a stressful virtual reality environment and its impact on working memory
    Published on 2019-07-11
    6 years ago
  • Adjunctive minocycline for major mental disorders: A systematic review
    Published on 2019-07-11
    6 years ago
  • Histone deacetylases inhibitor trichostatin A reverses anxiety-like symptoms and memory impairments induced by maternal binge alcohol drinking in mice
    Published on 2019-07-11
    6 years ago
  • Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates
    Published on 2019-07-11
    6 years ago
  • Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia
    Published on 2019-07-11
    6 years ago
  • Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
    Published on 2019-07-11
    6 years ago
  • Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model
    Published on 2019-07-10
    6 years ago
« Previous 1 … 117 118 119 120 121 … 134 Next »
European Neuropsychopharmacology
  • P.850Real-world effectiveness of aripiprazole long-acting injectable
    Published on 2020-11-25
    5 years ago
  • P.824Positive and negative symptoms, cognitive deficits and antipsychotic treatment in schizophrenic patients
    Published on 2020-11-25
    5 years ago
  • P.851Differences in healthcare resource utilization across oral atypical antipsychotic treatments in patients with schizophrenia
    Published on 2020-11-25
    5 years ago
  • P.829Clinical characteristics of schizophrenia offspring, children diagnosed with attention deficit hiperactivity disorder and healthy controls
    Published on 2020-11-25
    5 years ago
  • P.855Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: pooled analysis of double-blind, placebo-controlled 6-week studies
    Published on 2020-11-25
    5 years ago
  • P.830A systematic review of antidepressant use in patients with delusional disorder: when and how?
    Published on 2020-11-25
    5 years ago
  • P.856Evidence-based psychoeducational program in first psychotic episode patients
    Published on 2020-11-25
    5 years ago
« Previous 1 … 117 118 119 120 121 … 153 Next »

   Pharma Pub